tiprankstipranks
Skye Bioscience (SKYE)
NASDAQ:SKYE
US Market
Holding SKYE?
Track your performance easily

Skye Bioscience (SKYE) Financial Statements

209 Followers

Skye Bioscience Financial Overview

Skye Bioscience's market cap is currently ―. The company's EPS TTM is $-0.842; its P/E ratio is -6.53; Skye Bioscience is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.25. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.90M$ -7.89M$ 4.58M$ 38.88M$ -24.65M
EBITDA$ -3.72M$ -7.61M$ 4.85M$ 39.14M$ -24.62M
Net Income Common Stockholders$ -3.90M$ -7.90M$ -5.02M$ -4.42M$ -24.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 67.41M$ 74.12M$ 83.34M$ 1.26M$ 5.13M
Total Assets$ 81.54M$ 87.26M$ 94.84M$ 11.94M$ 15.60M
Total Debt$ 190.99K$ 5.07M$ 4.84M$ 4.62M$ 4.43M
Net Debt$ -67.22M$ -69.05M$ -78.51M$ 3.36M$ -699.90K
Total Liabilities$ 5.73M$ 14.45M$ 15.95M$ 14.07M$ 13.91M
Stockholders Equity$ 75.80M$ 72.81M$ 78.88M$ -2.13M$ 1.70M
Cash Flow-
Free Cash Flow$ -6.71M$ -7.13M$ -3.57M$ -3.85M$ -4.06M
Operating Cash Flow$ -5.26M$ -7.09M$ -4.71M$ -3.84M$ -4.05M
Investing Cash Flow$ -1.45M$ -32.46K$ 1.14M$ -7.02K$ 1.07M
Financing Cash Flow-$ -2.10M$ 85.65M$ -22.65K$ 16.63M
Currency in USD

Skye Bioscience Earnings and Revenue History

Skye Bioscience Debt to Assets

Skye Bioscience Cash Flow

Skye Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis